Don't Miss SCAI President Dr. Kirk Garratt at the NYSE Closing Bell Today
In recognition of National Heart Valve Disease Awareness Day, SCAI will join The Alliance for Aging Research and other campaign supporters in ringing the closing bell at the New York Stock Exchange.
You can watch a live stream of the event online starting at 3:56 p.m. ET today, Feb. 22. Be sure to follow events throughout the day on social media using #ValveDiseaseDay.
SCAI IN THE NEWS
Improving Patient Care and Post Procedure Efficiency Following Transradial Access
Cath Lab Digest
While transitioning to a primary transradial operator and establishing a transradial program can initially seem to be formidable tasks, there are plethora of resources to help the operator learn the skill set needed to make this transition successful. Programs, such as the Society for Cardiovascular Angiography and Interventions Transradial Intervention Program program, provide not only physician education, but also staff education focused on appropriate cath lab setup and peri-procedural care. READ MORE
Effect of Pulsara on D2B Times [Research]
In the cohort of patients, the utilization of the Pulsara platform decreased the average door-to-balloon times by 22% in patients with acute STEMI arriving at the emergency department. This effect was maintained when looking at the subset of all STEMI cases reportable to CMS. Researchers also observed modest improvements in meeting the less than 60-minute, less than 90-minute benchmarks, and improvements in the resource utilization. Read the full Critical Pathways in Cardiology publication here. READ MORE
Promoted by Pulsara
. SPONSOR SPOTLIGHT
Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients
A new meta-analysis is helping to fill a knowledge gap regarding the optimal duration of dual antiplatelet therapy (DAPT) in elderly patients treated with drug-eluting stents, supporting a less-is-more approach. "The main clinical message is that short-term DAPT may be considered in elderly patients receiving next-generation drug-eluting stents to reduce bleeding events without an increase of ischemic events," study co-author Myeong-Ki Hong, MD, told TCTMD in an email, adding that he would like to see future randomized trials look at this issue. READ MORE
Reduce Dye. Reduce Risk.
Society guidelines state the need to reduce dye in high risk patients as part of a strategy to reduce risk of AKI in the cath lab. Osprey Medical's DyeVert™ Plus System is the only technology proven to consistently monitor and reduce dye dosage delivered to patients undergoing coronary angiography procedures.
1st Patient Enrolled in DAPT Duration Trial
Abbott recently announced the first patient enrollment for a trial evaluating shorter-duration dual antiplatelet therapy (DAPT) in patients at high risk for bleeding after everolimus-eluting coronary stent implantation. Typically, patients are prescribed DAPT for one year after receiving a stent. READ MORE
Hospital Reduces D2B by 30%
After implementing process changes including the use of Pulsara to coordinate care, St. Elizabeth Healthcare reduced their door-to-balloon time by 30%. Read the case study!
Cardiac Catheterization Labs May Be More Efficient With Quality Improvement Initiative
HealthDay News via The Cardiology Advisor
A quality improvement intervention can reduce inefficiencies in the cardiac catheterization lab, according to a recent study. Grant W. Reed, MD, from the Cleveland Clinic in Ohio, and colleagues performed an observational study to report metrics of efficiency before and after implementation of a cath lab quality improvement program in June 2014, which included implementation of a pyramidal nursing schedule, increased use of an electronic scheduling system and increased utilization of a prep/recovery area. READ MORE
CABG Best for Diabetics With Multivessel CAD, Low LVEF
Left ventricular dysfunction did not make percutaneous coronary intervention (PCI) the better choice for revascularization in patients with diabetes and multivessel coronary artery disease, researchers found. When left ventricular ejection fraction fell below 50 percent, this group of PCI recipients was at a disadvantage compared to peers who received coronary artery bypass grafting: combined death, stroke, myocardial infarction and repeat revascularization rates over five years were 51 percent and 28 percent, respectively among those with moderate LV dysfunction; and 61 percent and 29 percent with severe dysfunction, according to Jayan Nagendran, MD, PhD, of University of Alberta and Mazankowski Alberta Heart Institute in Edmonton, and colleagues. READ MORE
RN ECMO Specialist, Clinical Nurse Johns Hopkins All Children's Hospital St. Petersburg, Florida
Clinical Cardiac Electrophysiology Fellowship Program Position University of Florida Jacksonville Jacksonville, Florida
Practice Administrator Mid America Heart & Lung Surgeons Kansas City, Missouri
Feb. 22-24, 2018 Cardiovascular Summit: Contemporary Strategies for Quality Improvement, Operational Excellence, Finance and Leadership Las Vegas, NV
March 21-24, 2018 Scottsdale Interventional Forum (SIF) Scottsdale, AZ
April 25-28, 2018 SCAI 2018 Scientific Sessions San Diego, CA
April 27-28, 2018 Women in Innovations Physician Leadership Summit San Diego, CA
April 27-28, 2018 Fellows Summit for Complex Cases San Diego, CA
Oct. 12-13, 2018 SCAI Shock 2018 Boston, MA
Katina Smallwoood, Assistant Executive Editor, 469-420-2675 | Contribute news